Literature DB >> 32770207

Sex Hormones and Incident Heart Failure in Men and Postmenopausal Women: The Atherosclerosis Risk in Communities Study.

Di Zhao1, Eliseo Guallar1, Christie M Ballantyne2, Wendy S Post1,3, Pamela Ouyang3, Dhananjay Vaidya1,4, Xiaoming Jia5, Wendy Ying3, Vinita Subramanya6, Chiadi E Ndumele1,3, Ron C Hoogeveen2, Erin D Michos1,3.   

Abstract

CONTEXT: Sex differences exist in heart failure (HF) phenotypes, but there is limited research on the role of sex hormones in HF and its subtypes.
OBJECTIVE: To examine the associations of total testosterone, dehydroepiandrosterone sulfate (DHEA-S), and sex hormone-binding globulin (SHBG) with incident HF, HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF).
DESIGN: Atherosclerosis Risk in Communities (ARIC) study (prospective cohort study). Median follow-up is 19.2 years.
SETTING: General community. PARTICIPANTS: 4107 men and 4839 postmenopausal women, with mean age of 63.2 (standard deviation [SD] 5.7) and 62.8 (5.5) years, respectively. EXPOSURE: Plasma sex hormone levels were measured at visit 4 (1996-1998). MAIN OUTCOME MEASURES: Incident HF events were identified through hospital discharge codes and death certificates.
RESULTS: The Hazard Ratios for HF associated with 1 SD decrease in log-transformed total testosterone, DHEA-S, and SHBG were 1.10 (95% confidence interval 1.03, 1.17), 1.07 (1.00, 1.15), and 1.04 (0.96, 1.11) in men, and 1.05 (0.99, 1.13), 1.17 (1.09, 1.24), and 0.93 (0.85, 1.01) in women, respectively. The associations between sex hormones with subtypes of HF had similar patterns but were attenuated and became statistically insignificant.
CONCLUSION: In this prospective cohort, lower levels of endogenous testosterone and DHEA-S in men and DHEA-S in postmenopausal women were associated with the development of HF. Similar directions of association in both sexes and both HF subtypes suggest that sex hormones play a role in the development of HF through common pathways regardless of sex. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  DHEA-S; HFpEF; HFrEF; SHBG; heart failure; sex hormone; testosterone

Mesh:

Substances:

Year:  2020        PMID: 32770207      PMCID: PMC7455306          DOI: 10.1210/clinem/dgaa500

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  42 in total

1.  Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): ARIC Study Community Surveillance.

Authors:  Patricia P Chang; Lisa M Wruck; Eyal Shahar; Joseph S Rossi; Laura R Loehr; Stuart D Russell; Sunil K Agarwal; Suma H Konety; Carlos J Rodriguez; Wayne D Rosamond
Journal:  Circulation       Date:  2018-03-08       Impact factor: 29.690

Review 2.  Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis.

Authors:  Johannes B Ruige; Ahmed M Mahmoud; Dirk De Bacquer; Jean-Marc Kaufman
Journal:  Heart       Date:  2010-12-21       Impact factor: 5.994

Review 3.  Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.

Authors:  Anna L Beale; Philippe Meyer; Thomas H Marwick; Carolyn S P Lam; David M Kaye
Journal:  Circulation       Date:  2018-07-10       Impact factor: 29.690

4.  Supra-physiological dose of testosterone induces pathological cardiac hypertrophy.

Authors:  Prapawadee Pirompol; Vassana Teekabut; Wattana Weerachatyanukul; Tepmanas Bupha-Intr; Jonggonnee Wattanapermpool
Journal:  J Endocrinol       Date:  2016-02-05       Impact factor: 4.286

5.  Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study.

Authors:  Ferdinando Iellamo; Maurizio Volterrani; Giuseppe Caminiti; Roger Karam; Rosalba Massaro; Massimo Fini; Peter Collins; Giuseppe M C Rosano
Journal:  J Am Coll Cardiol       Date:  2010-10-12       Impact factor: 24.094

6.  Association of endogenous testosterone with blood pressure and left ventricular mass in men. The Tromsø Study.

Authors:  Johan Svartberg; Denise von Mühlen; Henrik Schirmer; Elizabeth Barrett-Connor; Johan Sundfjord; Rolf Jorde
Journal:  Eur J Endocrinol       Date:  2004-01       Impact factor: 6.664

7.  Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women.

Authors:  E Barrett-Connor; D Goodman-Gruen
Journal:  BMJ       Date:  1995-11-04

Review 8.  Testosterone replacement therapy and cardiovascular risk.

Authors:  Thiago Gagliano-Jucá; Shehzad Basaria
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

9.  Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals.

Authors:  Nathalie Conrad; Andrew Judge; Jenny Tran; Hamid Mohseni; Deborah Hedgecott; Abel Perez Crespillo; Moira Allison; Harry Hemingway; John G Cleland; John J V McMurray; Kazem Rahimi
Journal:  Lancet       Date:  2017-11-21       Impact factor: 79.321

Review 10.  A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications.

Authors:  Anna L Goldman; Shalender Bhasin; Frederick C W Wu; Meenakshi Krishna; Alvin M Matsumoto; Ravi Jasuja
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 25.261

View more
  7 in total

1.  Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.

Authors:  Nathan D Wong; Matthew J Budoff; Keith Ferdinand; Ian M Graham; Erin D Michos; Tina Reddy; Michael D Shapiro; Peter P Toth
Journal:  Am J Prev Cardiol       Date:  2022-03-15

Review 2.  Special Considerations in the Care of Women With Advanced Heart Failure.

Authors:  Imo A Ebong; Ersilia M DeFilippis; Eman A Hamad; Eileen M Hsich; Varinder K Randhawa; Filio Billia; Mahwash Kassi; Anju Bhardwaj; Mirnela Byku; Mrudala R Munagala; Roopa A Rao; Amy E Hackmann; Claudia G Gidea; Teresa DeMarco; Shelley A Hall
Journal:  Front Cardiovasc Med       Date:  2022-07-11

3.  Relationship Between Age at Menopause, Obesity, and Incident Heart Failure: The Atherosclerosis Risk in Communities Study.

Authors:  Imo A Ebong; Machelle D Wilson; Duke Appiah; Erin D Michos; Susan B Racette; Amparo Villablanca; Khadijah Breathett; Pamela L Lutsey; Melissa Wellons; Karol E Watson; Patricia Chang; Alain G Bertoni
Journal:  J Am Heart Assoc       Date:  2022-04-13       Impact factor: 6.106

Review 4.  Evaluation of the Interaction of Sex Hormones and Cardiovascular Function and Health.

Authors:  Myrthe M A Willemars; Miranda Nabben; Job A J Verdonschot; Martijn F Hoes
Journal:  Curr Heart Fail Rep       Date:  2022-05-28

5.  Coexistence of bone and vascular disturbances in patients with endogenous glucocorticoid excess.

Authors:  Chieko Yano; Maki Yokomoto-Umakoshi; Masamichi Fujita; Hironobu Umakoshi; Seiichi Yano; Norifusa Iwahashi; Shunsuke Katsuhara; Hiroki Kaneko; Masatoshi Ogata; Tazuru Fukumoto; Eriko Terada; Yayoi Matsuda; Ryuichi Sakamoto; Yoshihiro Ogawa
Journal:  Bone Rep       Date:  2022-08-11

Review 6.  Cardiovascular risk and testosterone - from subclinical atherosclerosis to lipoprotein function to heart failure.

Authors:  Baris Gencer; Marco Bonomi; Maria Pia Adorni; Cesare R Sirtori; François Mach; Massimiliano Ruscica
Journal:  Rev Endocr Metab Disord       Date:  2021-02-22       Impact factor: 6.514

Review 7.  Endocrine Challenges in Patients with Continuous-Flow Left Ventricular Assist Devices.

Authors:  Gennaro Martucci; Federico Pappalardo; Harikesh Subramanian; Giulia Ingoglia; Elena Conoscenti; Antonio Arcadipane
Journal:  Nutrients       Date:  2021-03-05       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.